The first cases of collagenous sprue successfully treated with thioguanine
Objective Collagenous sprue (CS) is a rare form of small bowel enteropathy characterised by a thickened basement membrane and is, in most of the literature, reported as part of coeliac disease. Multiple treatment strategies are suggested in CS, but there is no standardised therapy. The aim of this s...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2016-06-01
|
Series: | BMJ Open Gastroenterology |
Online Access: | https://bmjopengastro.bmj.com/content/3/1/e000099.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823857154162950144 |
---|---|
author | Chris J J Mulder Gerd Bouma Tom van Gils Tine van de Donk Foke van Delft E Andra Neefjes-Borst |
author_facet | Chris J J Mulder Gerd Bouma Tom van Gils Tine van de Donk Foke van Delft E Andra Neefjes-Borst |
author_sort | Chris J J Mulder |
collection | DOAJ |
description | Objective Collagenous sprue (CS) is a rare form of small bowel enteropathy characterised by a thickened basement membrane and is, in most of the literature, reported as part of coeliac disease. Multiple treatment strategies are suggested in CS, but there is no standardised therapy. The aim of this series is to describe 4 cases of CS and to propose thioguanine (6-TG) treatment.Design We reviewed 4 cases of CS. Data were obtained from our prospective database of patients referred to our coeliac centre. Evaluation of small bowel biopsies was performed by an expert pathologist.Results None of the patients had ever had coeliac-specific antibodies, and all were negative for HLA-DQ2 and HLA-DQ8 phenotype. Three patients were treated with a combination of 6-TG and budesonide, and 1 patient received 6-TG only. All patients improved remarkably. Normalisation of the thickened basement membrane was found in 2 patients and complete histological improvement including full recovery of villi was found in 1 patient. In the third patient, the thickened basement membrane was only very focally recognised. The thickened membrane persisted in the last patient, probably because of the short time of follow-up.Conclusions CS should be separated from coeliac disease. Based on the lack of typical HLA phenotyping and the absence of coeliac-specific antibodies, there seems to be no relation with coeliac disease in these 4 cases. A promising treatment option might be 6-TG with or without budesonide. Research in a larger cohort is needed to standardise treatment for CS. |
format | Article |
id | doaj-art-af8fea49ba614afa9e432323fcbf98c4 |
institution | Kabale University |
issn | 2054-4774 |
language | English |
publishDate | 2016-06-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Open Gastroenterology |
spelling | doaj-art-af8fea49ba614afa9e432323fcbf98c42025-02-11T23:10:10ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742016-06-013110.1136/bmjgast-2016-000099The first cases of collagenous sprue successfully treated with thioguanineChris J J Mulder0Gerd Bouma1Tom van Gils2Tine van de Donk3Foke van Delft4E Andra Neefjes-Borst53 Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands1Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands7 Department of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands1Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands1Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands2Department of Pathology, VU University Medical Center, Amsterdam, The NetherlandsObjective Collagenous sprue (CS) is a rare form of small bowel enteropathy characterised by a thickened basement membrane and is, in most of the literature, reported as part of coeliac disease. Multiple treatment strategies are suggested in CS, but there is no standardised therapy. The aim of this series is to describe 4 cases of CS and to propose thioguanine (6-TG) treatment.Design We reviewed 4 cases of CS. Data were obtained from our prospective database of patients referred to our coeliac centre. Evaluation of small bowel biopsies was performed by an expert pathologist.Results None of the patients had ever had coeliac-specific antibodies, and all were negative for HLA-DQ2 and HLA-DQ8 phenotype. Three patients were treated with a combination of 6-TG and budesonide, and 1 patient received 6-TG only. All patients improved remarkably. Normalisation of the thickened basement membrane was found in 2 patients and complete histological improvement including full recovery of villi was found in 1 patient. In the third patient, the thickened basement membrane was only very focally recognised. The thickened membrane persisted in the last patient, probably because of the short time of follow-up.Conclusions CS should be separated from coeliac disease. Based on the lack of typical HLA phenotyping and the absence of coeliac-specific antibodies, there seems to be no relation with coeliac disease in these 4 cases. A promising treatment option might be 6-TG with or without budesonide. Research in a larger cohort is needed to standardise treatment for CS.https://bmjopengastro.bmj.com/content/3/1/e000099.full |
spellingShingle | Chris J J Mulder Gerd Bouma Tom van Gils Tine van de Donk Foke van Delft E Andra Neefjes-Borst The first cases of collagenous sprue successfully treated with thioguanine BMJ Open Gastroenterology |
title | The first cases of collagenous sprue successfully treated with thioguanine |
title_full | The first cases of collagenous sprue successfully treated with thioguanine |
title_fullStr | The first cases of collagenous sprue successfully treated with thioguanine |
title_full_unstemmed | The first cases of collagenous sprue successfully treated with thioguanine |
title_short | The first cases of collagenous sprue successfully treated with thioguanine |
title_sort | first cases of collagenous sprue successfully treated with thioguanine |
url | https://bmjopengastro.bmj.com/content/3/1/e000099.full |
work_keys_str_mv | AT chrisjjmulder thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine AT gerdbouma thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine AT tomvangils thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine AT tinevandedonk thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine AT fokevandelft thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine AT eandraneefjesborst thefirstcasesofcollagenousspruesuccessfullytreatedwiththioguanine AT chrisjjmulder firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine AT gerdbouma firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine AT tomvangils firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine AT tinevandedonk firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine AT fokevandelft firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine AT eandraneefjesborst firstcasesofcollagenousspruesuccessfullytreatedwiththioguanine |